Phase II Clinical Study of Adebrelimab Combined with Apatinib in the Treatment of Locally Advanced Non-small Cell Lung Cancer Patients with Radiation Pneumonitis
PHASE2Active, not recruitingINTERVENTIONAL
Enrollment
32
Participants
Timeline
Start Date
August 13, 2024
Primary Completion Date
December 31, 2024
Study Completion Date
December 31, 2026
Conditions
Unresectable Locally Advanced Non-small Cell Lung Cancer
Interventions
DRUG
Adebrelimab + Apatinib
Adebrelimab combined with apatinib
Trial Locations (1)
Unknown
Chongqing University Cancer Hospital, Chongqing
All Listed Sponsors
lead
Wei Zhou
OTHER
NCT06700421 - Phase II Clinical Study of Adebrelimab Combined with Apatinib in the Treatment of Locally Advanced Non-small Cell Lung Cancer Patients with Radiation Pneumonitis | Biotech Hunter | Biotech Hunter